NEW YORK--(BUSINESS WIRE)--Viriathus Research LLC, an independent research firm, issued an Overview Report today for Biosceptre International Limited, a public, unlisted Australian biotech company that is developing a range of patented antibodies with applications in the diagnosis and treatment of cancer. The report provides a description of Biosceptre’s business, industry, product, strategy, management team, and investment opportunities and risks. The report is available free of charge at
For more information, please visit
http://www.businesswire.com/news/home/20100217005299/en